|
US5703073A
(en)
*
|
1995-04-19 |
1997-12-30 |
Nitromed, Inc. |
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
|
|
US6043232A
(en)
*
|
1997-07-23 |
2000-03-28 |
Nitromed, Inc. |
Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
|
|
GB9801398D0
(en)
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
IT1298338B1
(it)
*
|
1998-03-05 |
1999-12-20 |
Nicox Sa |
Composizioni farmaceutiche per l'ulcera
|
|
CA2348741C
(en)
|
1998-10-30 |
2010-04-20 |
Nitromed Inc. |
Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
|
|
TWI243672B
(en)
*
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
|
US6436990B1
(en)
|
1999-10-27 |
2002-08-20 |
Nobex Corporation |
6-methoxy-2-naphthylacetic acid prodrugs
|
|
US6552078B2
(en)
|
1999-10-27 |
2003-04-22 |
Nobex Corp |
6-methoxy-2-naphthylacetic acid prodrugs
|
|
TWI262791B
(en)
|
1999-10-27 |
2006-10-01 |
Nobex Corp |
6-methoxy-2-naphthylacetic acid prodrugs
|
|
CA2393724A1
(en)
|
1999-12-23 |
2001-06-28 |
Nitromed, Inc. |
Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
|
|
EP1251840A2
(en)
*
|
2000-01-26 |
2002-10-30 |
Cedars-Sinai Medical Center |
Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
|
|
US7018979B1
(en)
|
2000-01-26 |
2006-03-28 |
Cedars-Sinai Medical Center |
Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
|
|
DE60122939T2
(de)
|
2000-12-21 |
2007-01-11 |
Nitromed, Inc., Bedford |
Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
|
|
EP1219306A1
(en)
*
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
US7211561B2
(en)
|
2001-10-12 |
2007-05-01 |
Cedars-Sinai Medical Center |
Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
|
|
AU2003226603A1
(en)
|
2002-04-19 |
2003-11-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
|
|
AU2003248642A1
(en)
|
2002-06-11 |
2003-12-22 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
CA2492066A1
(en)
|
2002-06-28 |
2004-01-08 |
Nitromed, Inc. |
Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
CA2491127A1
(en)
|
2002-07-03 |
2004-01-15 |
Nitromed, Inc. |
Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
CA2493156A1
(en)
|
2002-07-29 |
2004-02-05 |
Nitromed, Inc. |
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
SE0300971D0
(sv)
*
|
2003-04-03 |
2003-04-03 |
Aga Ab |
Nitric oxide in treatment of inflammation
|
|
WO2005070868A1
(en)
*
|
2004-01-27 |
2005-08-04 |
Merck Frosst Company |
Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
|
|
KR20070045187A
(ko)
*
|
2004-06-10 |
2007-05-02 |
고쿠리츠다이가쿠호진 도호쿠다이가쿠 |
항암제의 효과 증강제
|
|
JP2007325501A
(ja)
*
|
2004-08-25 |
2007-12-20 |
Tottori Univ |
非ステロイド性抗炎症薬による動物の消化管副作用の予防・治療方法
|
|
EP3556401A1
(en)
|
2005-05-27 |
2019-10-23 |
The University of North Carolina at Chapel Hill |
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
|
|
US20100240745A1
(en)
*
|
2009-03-20 |
2010-09-23 |
Nicox S.A. |
Method of treatment of inflammation in hypertensive patients
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
US9919072B2
(en)
|
2009-08-21 |
2018-03-20 |
Novan, Inc. |
Wound dressings, methods of using the same and methods of forming the same
|
|
US8591876B2
(en)
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
|
EP2681286B1
(en)
|
2011-02-28 |
2018-08-15 |
Novan, Inc. |
Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
|
|
JO3350B1
(ar)
|
2011-03-07 |
2019-03-13 |
Merck Sharp & Dohme |
مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
|
|
RU2539630C1
(ru)
*
|
2013-07-09 |
2015-01-20 |
Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") |
Способ профилактики ишемии сетчатки в эксперименте
|
